Artículos de revistas
Cytotoxicity Of Goniothalamin Enantiomers In Renal Cancer Cells: Involvement Of Nitric Oxide, Apoptosis And Autophagy
Registro en:
Chemico-biological Interactions. , v. 176, n. 2-3, p. 143 - 150, 2008.
92797
10.1016/j.cbi.2008.08.003
2-s2.0-55249110167
Autor
de Fatima A.
Zambuzzi W.F.
Modolo L.V.
Tarsitano C.A.B.
Gadelha F.R.
Hyslop S.
Carvalho J.E.d.
Salgado I.
Ferreira C.V.
Pilli R.A.
Institución
Resumen
Goniothalamin is a styryllactone synthesized by plants of the genus Goniothalamus. The biological activities of this molecule, particularly its anti-protozoan, anti-fungal, and larvicidal properties, have received considerable attention. In this work, we investigated the action of the natural and synthetic enantiomers (R)-goniothalamin (1) and (S)-goniothalamin (ent-1) on cell viability, nitric oxide synthase (NOS) expression and activity, and the expression of selected proteins involved in apoptosis and autophagy in renal cancer cells. Both compounds were cytotoxic and decreased the mitochondrial function of renal cancer cells. However, the enantiomers differentially affected the expression/activity profiles of some signaling pathway mediators. Ent-1 (4 nM) was more potent than 1 (6.4 μM) in inhibiting constitutive NOS activity (54% and 59% inhibition, respectively), and both enantiomers decreased the protein expression of neuronal and endothelial NOS, as assessed by western blotting. Ent-1 and 1 caused down-regulation of Ras and TNFR1 and inhibition of protein serine/threonine phosphatase 2A (PP2A). Compound 1 markedly down-regulated Bcl2, an anti-apoptotic protein, and also induced PARP cleavage. Despite inducing an expressive down-regulation of Bax, ent-1 was also able to induce PARP cleavage. These results suggest that these compounds caused apoptosis in renal cancer cells. Interestingly, ent-1 enhanced the expression of LC3, a typical marker of autophagy. NFκB was down-regulated in 1-treated cells. Overall, these results indicate that the anti-proliferative activity of the two enantiomers on renal cancer cells involved distinct signaling pathways, apoptosis and autophagy as dominant responses towards 1 and ent-1, respectively. © 2008 Elsevier Ireland Ltd. All rights reserved. 176 2-3 143 150 Blázquez, M.A., Bermejo, A., Zafra-Polo, M.C., Cortes, D., Styryllactones from Goniothalamus species-a review (1999) Phytochem. Anal., 10, pp. 161-170 de Fátima, A., Modolo, L.V., Conegero, L.S., Pilli, R.A., Ferreira, C.V., Kohn, L.K., de Carvalho, J.E., Styryllactones and their derivatives: biological activities, mechanism of action and potential leads for drug design (2006) Curr. Med. Chem., 13, pp. 3371-3384 Ali, A.M., Mackeen, M.M., Hamid, M., Aun, Q.B., Zauyah, Y., Azimahtol, H.L.P., Kawazu, K., Cytotoxicity and electron microscopy of cell death induced by goniothalamin (1997) Planta Med., 63, pp. 81-83 Cao, S.G., Wu, X.H., Sim, K.Y., Tan, B.K.H., Pereira, J.T., Goh, S.H., Styryllactone derivatives and alkaloids from Goniothalamus borneensis (Annonaceae) (1998) Tetrahedron, 54, pp. 2143-2148 Hawariah, A., Stanslas, J., Antagonistic effects of styrylpyrone derivative (SPD) on 7,12-dimethylbenzanthracene-induced rat mammary tumors (1998) In Vivo, 12, pp. 403-410 Bermejo, A., Leonce, S., Cabedo, N., Andreu, I., Caignard, D.H., Atassi, G., Cortes, D., Semisynthesis and cytotoxicity of styryllactone derivatives (1999) J. Nat. Prod., 62, pp. 1106-1109 Mosaddik, M.A., Haque, M.E., Cytotoxicity and antimicrobial activity of goniothalamin isolated from Bryonopsis laciniosa (2003) Phytother. Res., 17, pp. 1155-1157 Lan, Y.H., Chang, F.R., Yu, J.H., Yang, Y.L., Chang, Y.L., Lee, S.J., Wu, Y.C., Cytotoxic styrylpyrones from Goniothalamus amuyon (2003) J. Nat. Prod., 66, pp. 487-490 Chan, K.M., Rajab, N.F., Ishak, M.H.A., Ali, A.M., Yusoff, K., Din, L.B., Inayat-Hussain, S.H., Goniothalamin induces apoptosis in vascular smooth muscle cells (2006) Chem. Biol. Int., 159, pp. 129-140 de Fátima, A., Kohn, L.K., de Carvalho, J.E., Pilli, R.A., Cytotoxic activity of (S)-goniothalamin and analogues against human cancer cells (2006) Bioorg. Med. Chem., 14, pp. 622-631 Inayat-Hussain, S.H., Annuar, B.O., Din, L.B., Ali, A.M., Ross, D., Loss of mitochondrial transmembrane potential and caspase-9 activation during apoptosis induced by the novel styryllactone goniothalamin in HL-60 leukemia cells (2003) Toxicol. In Vitro, 17, pp. 433-439 Inayat-Hussain, S.H., Osman, A.B., Din, L.B., Ali, A.M., Snowden, R.T., MacFarlane, M., Cain, K., Caspases-3 and -7 are activated in goniothalamin-induced apoptosis in human Jurkat T-cells (1999) FEBS Lett., 456, pp. 379-383 Pihie, A.H.L., Stanslas, J., Din, L.B., Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines (1998) Anticancer Res., 18, pp. 1739-1744 de Fátima, A., Kohn, L.K., Antônio, M.A., de Carvalho, J.E., Pilli, R.A., (R)-Goniothalamin: total synthesis and cytotoxic activity against cancer cell lines (2005) Bioorg. Med. Chem., 13, pp. 2927-2933 Martins, C.V.B., de Resende, M.A., Magalhães, T.F.F., Lima, B.H.S., Watanabe, G.A., Ruiz, A.L.T.G., de Carvalho, J.E., de Fátima, A., Antifungal activity of goniothalamin enantiomers (2008) Lett. Drug Design Dis., 5, pp. 74-78 Meenakshii, N., Lee, A., Azimahtol, H.L.P., Hasidah, S., Increased levels of apoptosis correlate with p53 protein accumulation in response to the styrylpyrone derivative (SPD) treatment of the Huggins tumor (2000) Malays. Appl. Biol., 29, pp. 121-126 Lee, A.T.C., Azimahtol, H.L.P., Tan, A.N., Styrylpyrone derivative (SPD) induces apoptosis in a caspase-7-dependent manner in the human breast cancer cell line MCF-7 (2003) Cancer Cell Int., 3, pp. 1-8 Kerr, J.F.R., Wyllie, A.H., Currie, A.R., Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics (1972) Br. J. Cancer, 26, pp. 239-257 Dlamini, Z., Mbita, Z., Zungu, M., Genealogy, expression, and molecular mechanisms in apoptosis (2004) Pharmacol. Therap., 101, pp. 1-15 Teoh, P.L., Azimahtol, H.L.P., Effects of styrylpyrone derivative (SPD) on expression of Blc-2 and Bax genes in human ovarian carcinoma cell line (1999) Malays. Appl. Biol., 28, pp. 107-111 Brüne, B., von Knethen, A., Sandau, K.B., Nitric oxide and its role in apoptosis (1998) Eur. J. Pharmacol., 351, pp. 261-272 Chung, H.T., Pae, H.O., Choi, B.M., Billiar, T.R., Nitric oxide as a bioregulator of apoptosis (2001) Biochem. Biophys. Res. Commun., 282, pp. 1075-1079 Moncada, S., Higgs, A., The l-arginine-nitric oxide pathway (1993) N.Engl. J. Med., 329, pp. 2002-2012 Cui, S., Reichner, J.S., Mateo, R.B., Albina, J.E., Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms (1994) Cancer Res., 54, pp. 2462-2467 Brüne, B., von Knethen, A., Sandau, K.B., Nitric oxide (NO): an effector of apoptosis (1999) Cell Death Differ., 6, pp. 969-975 Xie, K., Huang, S., Dong, Z., Gutman, M., Fidler, I.J., Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362 (1995) Cancer Res., 55, pp. 3123-3131 Xie, K., Huang, S., Dong, Z., Juang, S.H., Gutman, M., Xie, Q., Nathan, C., Fidler, I.J., Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells (1995) J. Exp. Med., 81, pp. 1333-1343 Dong, Z.Y., Staroselsky, A.H., Qi, X.X., Xie, K.P., Fidler, I., Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells (1994) J. Cancer Res., 54, pp. 789-793 Xie, K., Huang, S., Contribution of nitric oxide-mediated apoptosis to cancer metastasis inefficiency (2003) Free Rad. Biol. Med., 34, pp. 969-986 Brennan, P.A., The actions and interactions of nitric oxide in solid tumors (2000) Eur. J. Surg. Oncol., 26, pp. 434-437 Alexandrova, R., Mileva, M., Zvetkova, E., Nitric oxide and cancer (2001) Exp. Pathol. Parasitol., 4 (7), pp. 13-18 Thomsen, L.L., Miles, D.W., Role of nitric oxide in tumour progression: lessons from human tumours (1998) Cancer Met. Rev., 17, pp. 107-118 Thomsen, L.L., Lawton, F., Knowles, R., Beesley, J., Rivores-Moreno, V., Moncada, S., Nitric oxide synthase activity in human gynecological cancer (1994) Cancer. Res., 54, pp. 1352-1354 Thomsen, L.L., Miles, D.W., Happerfield, L., Bobrow, L.G., Knowles, R.G., Moncada, S., Nitric oxide synthase activity in human breast cancer (1995) Br. J. Cancer, 72, pp. 41-44 Rosbe, K.W., Prazmo, J., Petrusz, P., Mims, W., Ball, S.S., Weissler, M.C., Immunohistochemical characterization of nitric oxide synthetase activity in squamous cell carcinoma of the head and neck (1995) Otolaryngol. Head Neck Surg., 113, pp. 541-549 Dueñas-Gonzales, A., Isales, C.M., Abad-Hernandez, M.M., Gonzales-Sarmiento, R., Sangueza, O., Rodriguez-Commes, J., Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease (1997) Modern Pathol., 10, pp. 645-649 Murta, B.M.T., Machado, J.S., Zaparoli, M., Lara, V.C., Murta, E.F.C., The relationship of host immune cells, cytokine and nitric oxide production to tumor cells in ovarian carcinoma (1999) São Paulo Med. J., 2, pp. 87-92 Stromblad, S., Becker, J.C., Yebra, M., Brooks, P.C., Cheresh, D.A., Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis (1996) J. Clin. Invest., 98, pp. 426-433 Babaei, S., Teichert-Kuliszewska, K., Monge, J.C., Mohamed, F., Bendeck, M.P., Stewart, D.J., Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor (1998) Circ. Res., 82, pp. 1007-1015 de Wilt, J.H., Manusama, E.R., van Etten, B., van Tiel, S.T., Jorna, A.S., Seynhaeve, A.L., ten Hagen, T.L., Eggermont, A.M., Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions (2000) Br. J. Cancer, 83, pp. 1172-1176 Reis, L.A.G., Kosary, C.L., Hankey, B.F., Miller, B.A., Harras, A., Edwards, B.K., (1997) SEER Cancer Statistics Review, 1973-1994: Tables and Graphs, , National Cancer Institute, Bethesda, MD NIH Pub. No. 97-2789 Gago-Dominguez, M., Castelão, J.E., Yuan, J.M., Ross, R.K., Yu, M.C., Increased risk of renal cell carcinoma subsequent to hysterectomy (1999) Cancer Epidemiol. Biomarkers Prev., 8, pp. 999-1003 Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Boyd, M., Feasibility of a high-flux anticancer drug screen utilizing a diverse panel of human tumor cell lines in culture (1991) J. Natl. Cancer Inst., 83, pp. 757-766 Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J.T., Boyd, M.R., New colorimetric cytotoxicity assay for anticancer-drug screening (1990) J. Natl. Cancer Inst., 82, pp. 1107-1112 Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254 Gondim, F.J., Modolo, L.V., Campos, G.E.R., Salgado, I., Neuronal nitric oxide synthase is heterogeneously distributed in equine myofibers and highly expressed in endurance trained horses (2005) Can. J. Vet. Res., 69, pp. 46-52 Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 222, pp. 680-685 Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications (1979) Proc. Natl. Acad. Sci. U.S.A., 76, pp. 4350-4354 Boer, R., Ulrich, W.-R., Klein, T., Mirau, B., Haas, S., Baur, I., The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes (2000) Mol. Pharmacol., 58, pp. 1026-1034 Â de Fátima, L.V. Modolo, Plant natural products say "NO way" to mammalian nitric oxide synthases, in: G. Brahmachari (ed.), Natural Products: Chemistry, Biochemistry and Pharmacology, Alphascience International and Arosa Publishing House PVT, Ltd., 2008, pp. 21-53Petros, A., Bennett, D., Vallance, P., Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock (1991) Lancet, 338, pp. 1557-1558 Ying, L., Hofseth, L.J., An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer (2007) Cancer Res., 67, pp. 1407-1410 Chabrier, P.E., Demerle-Pallardy, C., Auguet, M., Nitric oxide synthases: targets for therapeutic strategies in neurological diseases (1999) Cell Mol. Life Sci., 55, pp. 1029-1035 Morio, L.A., Chiu, H., Sprowles, K.A., Zhou, P., Heck, D.E., Gordon, M.K., Laskin, D.L., Distinct roles of tumor necrosis factor-α and nitric oxide in acute liver injury induced by carbon tetrachloride in mice (2001) Toxicol. Appl. Pharmacol., 172, pp. 44-51 Tanaka, S., Yoichi, S., Ao, L., Mariko, M., Morimoto, K., Akimoto, N., Honda, G., Said, I.M., Potential immunosuppressive and antiinflammatory activities of Malaysian medicinal plants characterized by reduced cell surface expression of cell adhesion molecules (2001) Phytother. Res., 15, pp. 681-686 Levine, B., Kroemer, G., Autophagy in the pathogenesis of disease (2008) Cell, 132, pp. 27-42 Konstantinopoulos, P.A., Karamouzis, M.V., Papavassiliou, A.G., Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets (2007) Nat. Rev. Drug. Discov., 6, pp. 541-555 de Souza, A.C.S., Kodach, L., Gadelha, F.R., Bos, C.L., Cavagis, A.D., Aoyama, H., Peppelenbosch, M.P., Ferreira, C.V., A promising action of riboflavin as a mediator of leukaemia cell death (2006) Apoptosis, 11, pp. 1761-1771 Boudreau, R.T., Conrad, D.M., Hoskin, D.W., Differential involvement of reactive oxygen species in apoptosis caused by the inhibition of protein phosphatase 2A in Jurkat and CCRF-CEM human T-leukemia cells (2007) Exp. Mol. Pathol., 83, pp. 347-356